CD44 and nonpapillary renal cell carcinoma: The regulatory network involving circPPP6R3/miR-1238-3p/CD44 axis provided an insight into understanding the development and progression of ccRCC, and might offer a promising biomarker as well as a therapeutic approach for ccRCC.